Cardiovascular Diseases in HIV-infected Subjects (HIV-HEART Study)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01119729 |
Recruitment Status :
Completed
First Posted : May 10, 2010
Last Update Posted : May 10, 2010
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Detection of Frequency, Severity and Progression of Cardiovascular Diseases in Patients With HIV-infection. Effect on Cardiovascular Risk and Life Quality by Age, Gender, Classic Cardiovascular Risk Factors, HIV-specific Cardiovascular Risk Factors, Cardiovascular Medication, Antiretroviral Medication |
Study Type : | Observational |
Actual Enrollment : | 803 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Group/Cohort |
---|
HIV-infected Outpatients |
- Prevalence of cardiovascular diseasesPrevalence of cardiovascular diseases including coronary artery disease, congestive heart failure, peripheral arterial disease, cerebrovascular events, and valvular diseases.
- Prevalence of cardiovascular disordersPrevalence of cardiovascular disorders determined by electrocardiography, exercise testing, echocardiography, blood samples.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Age > 18 years
- Known HIV-infection
- Outpatients
- Written informed consent
Exclusion Criteria:
● Acute cardiovascular disease or unstable hemodynamic status in the three weeks before inclusion
• Pregnancy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01119729
Germany | |
Department of Dermatology, University Hospital of Bochum | |
Bochum, NRW, Germany, 44791 | |
HIV Outpatient Department | |
Dortmund, NRW, Germany, 44137 | |
HIV Outpatients Department | |
Duisburg, NRW, Germany, 47055 | |
HIV Outpatient Department | |
Duisburg, NRW, Germany, 47259 | |
Department of Dermatology, University Hospital of Essen | |
Essen, NRW, Germany, 45122 | |
West German Heart Center Essen | |
Essen, NRW, Germany, 45122 | |
HIV Outpatient Department | |
Essen, NRW, Germany, 45127 |
Other Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | PD Dr. med. Till Neumann, FESC, Competence Network of Heart Failure |
ClinicalTrials.gov Identifier: | NCT01119729 |
Other Study ID Numbers: |
FKZ 01GI0205 |
First Posted: | May 10, 2010 Key Record Dates |
Last Update Posted: | May 10, 2010 |
Last Verified: | May 2010 |
Cardiac Diseases • HIV-Infection • AIDS • Antiretroviral Therapy |
HIV Infections Cardiovascular Diseases Infections Blood-Borne Infections Communicable Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases |
Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases Immunologic Deficiency Syndromes Immune System Diseases |